Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.22.1
Stock Based Compensation (Details)
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance | shares 18,318,326
Number of shares, ending | shares 18,158,576
Number of shares, Grants | shares 0
Number of shares, Expirations | shares (150,000)
Number of shares, Exercises | shares (9,750)
Options exercisable, Ending balance | shares 18,158,576
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.53
Weighted Average Exercise Price, Grants | $ / shares 0
Weighted Average Exercise Price, Expirations | $ / shares 1.15
Weighted Average Exercise Price, Exercises | $ / shares 0.25
Weighted Average Exercise Price, Ending | $ / shares 0.53
Options exercisable, Ending balance | $ / shares $ 0.53
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 2 years 10 months 20 days
Weighted Average Remaining Contractual Life (years), Grants 0 years
Weighted Average Remaining Contractual Life (years), Ending balance 2 years 10 months 9 days
Options exercisable, Ending balance 2 years 10 months 9 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 2,961,965
Aggregate Intrinsic Value, Ending balance | $ 1,474,732
Options exercisable, Ending balance, Intrinsic value | $ $ 1,474,732